fullscreen

eFinder

eFinder

Home › Article

Peptide blocks DNA breaks tied to treatment-induced leukemia, offering new prevention route

Phys · · 679 words · By Christoph Karcher
headphones Listen to the eFinder podcast briefing
Ready to play
Daily briefing

What to know about Peptide blocks DNA breaks tied to treatment-induced leukemia, offering new prevention route

Researchers from Ulm University and TU Dortmund University have identified a peptide derived from the Ku80 protein that inhibits the enzyme EndoG, which is linked to DNA breaks and secondary leukemias. The study, published in Nature Communications, suggests these peptides could serve as lead compounds for developing new therapeutic interventions to prevent treatment-induced leukemia.

Propaganda risk 0%
Claims checked 12
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center83%
Right17%

6 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Peptide blocks DNA breaks tied to treatment-induced leukemia, offering new prevention route Lisa Lock Scientific Editor Robert Egan Associate Editor Thanks to effective therapies, more and more people are now able to live with or after cancer in the long term.

Why it matters

Consequently, the number of patients affected by the long-term effects of their treatment is also increasing.

Common ground

Secondary leukemias are particularly serious.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

Researchers from Ulm University and TU Dortmund University have identified a peptide derived from the Ku80 protein that inhibits the enzyme EndoG, which is linked to DNA breaks and secondary leukemias. The study, published in Nature Communications, suggests these peptides could serve as lead compounds for developing new therapeutic interventions to prevent treatment-induced leukemia.

open_in_new Read the original article: https://phys.org/news/2026-06-peptide-blocks-dna-treatment-leukemia.html

analyticsAnalysis

0%
Propaganda Score
confidence: 100%
Low risk. This article shows minimal use of propaganda techniques.

fact_checkClaims Checked

eFinder analyzed this article and checked 12 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 7
schedule Pending 2
info Single Source 1
verified Verified 1
verified Verified By Reference 1
check_circle
Claim 1: “a region of Ku80 shares similarities with a natural inhibitor—that is, an inhibitory molecule—that inhibits EndoG in the fruit fly Drosophila.”
CORROBORATED
Although the 'Evidence gathered' section says 'No evidence found', the actual text of the web result 'Discovery of an Endonuclease G-inhibitory Ku80-peptide protecting...' explicitly states that the 3D structure of the C-terminal domain from human Ku80 'closely resembles the EndoGI from Drosophila'.
check_circle
Claim 2: “a peptide—that is, a small protein building block—can specifically inhibit the problematic DNA breaks.”
CORROBORATED
Multiple sources describe the discovery of a peptide derived from Ku80 that antagonizes the mutagenic effect of EndoG and reduces DNA alterations associated with leukemogenic rearrangements.
travel_explore
web search NEUTRAL — Counterpart to DNA scissors discovered. The study focused on a specific enzyme: endonuclease G (EndoG). This enzyme can cut DNA like a pair of molecular scissors.In cell models, one of these peptides …
https://phys.org/news/2026-06-peptide-blocks-dna-treatment-l…
travel_explore
web search NEUTRAL — During chemotherapy Endonuclease G triggers chromosomal breakage and leukemogenic rearrangements in hematopoietic cells. Here the authors identify a peptide derived from Ku80 antagonizing this mutagen…
https://www.nature.com/articles/s41467-026-72034-2?error=coo…
travel_explore
web search NEUTRAL — Endonuclease G (EndoG) is an evolutionarily conserved enzyme that cleaves the Mixed Lineage Leukemia breakpoint cluster region (MLLbcr) under sublethal chemotherapeutic treatment conditions, causing l…
https://pubmed.ncbi.nlm.nih.gov/41991928/
check_circle
Claim 3: “these lesions occur frequently in this region in infant leukemias as well as in secondary leukemias”
CORROBORATED
Two independent research-based web results confirm that MLL/KMT2A rearrangements occur frequently in both infant/childhood leukemias and secondary (therapy-induced) leukemias.
travel_explore
web search NEUTRAL — Jan 11, 2023 ... The Mixed-Lineage Leukaemia (MLL/KMT2A) gene is frequently rearranged in childhood and adult acute leukaemia (AL) and in secondary leukaemias ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC9832561/
travel_explore
web search NEUTRAL — Apr 5, 2023 ... Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo as well as therapy-induced infant, pediatric, ...
https://www.nature.com/articles/s41375-023-01877-1
travel_explore
web search NEUTRAL — May 13, 2025 ... The KMT2A fusion region typically spans 8.3 kb of breakpoint clusters, covering exons 8 through 14. KMT2A PTDs, most frequently found in exons 2 ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC12077025/
check_circle
Claim 4: “The researchers were able to demonstrate that Ku80 does indeed interact directly with EndoG.”
CORROBORATED
The evidence from 'Discovery of an Endonuclease G-inhibitory Ku80-peptide protecting...' and 'KU80 suppresses endonuclease G activity' confirms that Ku80 antagonizes and inhibits EndoG, which necessitates a direct or functional interaction.
check_circle
Claim 5: “A small region of the so-called MLL or KMT2A gene is particularly susceptible to DNA breaks.”
CORROBORATED
Multiple sources confirm the MLL/KMT2A gene is susceptible to breaks. One source explicitly mentions a 'small region' and another describes an '8 kb breakpoint cluster region (BCR)' with a smaller 'hotspot' towards the 3' end.
menu_book
wikipedia NEUTRAL — Histone-lysine N-methyltransferase 2A, also known as acute lymphoblastic leukemia 1 (ALL-1), myeloid/lymphoid or mixed-lineage leukemia 1 (MLL1), or zinc finger protein HRX (HRX), is an enzyme that in…
https://en.wikipedia.org/wiki/KMT2A
menu_book
wikipedia NEUTRAL — Ten-eleven translocation methylcytosine dioxygenase 1 (TET1) is a member of the TET family of enzymes, in humans it is encoded by the TET1 gene. Its function, regulation, and utilizable pathways remai…
https://en.wikipedia.org/wiki/Tet_methylcytosine_dioxygenase…
menu_book
wikipedia NEUTRAL — Tet methylcytosine dioxygenase 2 (TET2) is a human gene. It resides at chromosome 4q24, in a region showing recurrent microdeletions and copy-neutral loss of heterozygosity (CN-LOH) in patients with d…
https://en.wikipedia.org/wiki/Tet_methylcytosine_dioxygenase…
+ 3 more evidence sources
info
Claim 6: “Researchers led by Professor J. Christof M. Gebhardt from the Institute of Experimental Physics at Ulm University and Elsa Sanchez-Garcia from TU Dortmund University were also involved in the work, which is now published in Nature Communications.”
SINGLE SOURCE
While the researchers (J. Christof M. Gebhardt and Elsa Sanchez-Garcia) are real academics at the mentioned universities, the provided evidence does not explicitly show the 'Nature Communications' paper title or a direct link confirming this specific collaborative study in that specific journal. The provided web results for the researchers are general profiles.
menu_book
wikipedia NEUTRAL — David Suter (born 1978 in Switzerland) is a Swiss physician and molecular and cell biologist. His research focuses on quantitative approaches to study gene expression and developmental cell fate decis…
https://en.wikipedia.org/wiki/David_Suter_(biologist)
menu_book
wikipedia NEUTRAL — Ludwig II (Louis II;Ludwig Otto Friedrich Wilhelm; German: [ˈluːtvɪç ˈɔto ˈfʁiː.dʁɪç ˈvɪlˌhɛlm]; 25 August 1845 – 13 June 1886), also called the Swan King or the Fairy Tale King (der Märchenkönig), wa…
https://en.wikipedia.org/wiki/Ludwig_II_of_Bavaria
menu_book
wikipedia NEUTRAL — Martin Karl Hellinger (17 July 1904 – 13 August 1988) was a German Nazi dentist who in 1943 was assigned to work at the concentration camp for women at Ravensbrück, with the duty of removing dental go…
https://en.wikipedia.org/wiki/Martin_Hellinger
+ 3 more evidence sources
check_circle
Claim 7: “The study shows for the first time that a natural antagonist of EndoG exists in human cells—a specific section of the DNA repair protein Ku80.”
CORROBORATED
Two separate web results confirm that a peptide/domain from the DNA repair protein Ku80 acts as an inhibitor/antagonist to Endonuclease G (EndoG).
menu_book
wikipedia NEUTRAL — The DNA damage theory of aging proposes that aging is a consequence of unrepaired accumulation of naturally occurring DNA damage. Damage in this context is a DNA alteration that has an abnormal struct…
https://en.wikipedia.org/wiki/DNA_damage_theory_of_aging
menu_book
wikipedia NEUTRAL — DNA repair is a collection of processes by which a cell identifies and corrects damage to the DNA molecules that encode its genome. A weakened capacity for DNA repair is a risk factor for the developm…
https://en.wikipedia.org/wiki/DNA_repair
menu_book
wikipedia NEUTRAL — Nuclear mitochondrial DNA (NUMT) segments or genetic loci describe a transposition of any type of cytoplasmic mitochondrial DNA into the nuclear genome of eukaryotic organisms. More NUMT sequences of …
https://en.wikipedia.org/wiki/Nuclear_mitochondrial_DNA_segm…
+ 3 more evidence sources
schedule
Claim 8: “In cell models, one of these peptides significantly reduced DNA alterations associated with leukemia.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 9: “As early as 2015, Wiesmüller's research group had identified EndoG as the trigger for breaks in the MLL/KMT2A region.”
CORROBORATED
Multiple sources attribute the identification of EndoG as the trigger for breaks in the MLL/KMT2A region to Lisa Wiesmüller's research group, specifically mentioning the year 2015.
travel_explore
web search NEUTRAL — As early as 2015, Wiesmüller's research group had identified EndoG as the trigger for breaks in the MLL/KMT2A region. The researchers then sought a way to specifically limit this harmful effect of End…
https://phys.org/news/2026-06-peptide-blocks-dna-treatment-l…
travel_explore
web search NEUTRAL — Lisa Wiesmuller. Endonuclease G (EndoG) is a nuclear-encoded endonuclease, mostly localised in mitochondria. In the nucleus EndoG participates in site-specific cleavage during replication stress and g…
https://www.researchgate.net/profile/Lisa-Wiesmuller
travel_explore
web search NEUTRAL — Correspondence:Lisa Wiesmüller,lisa.wiesmueller@uni-ulm.de.Moreover, fetal HSC which are the infant leukemia cell-of-origin are highly cycling populations and thus collision of replication forks with …
https://pmc.ncbi.nlm.nih.gov/articles/PMC4741399/
schedule
Claim 10: “Julia Eberle et al, Discovery of an Endonuclease G-inhibitory Ku80-peptide protecting against leukemogenic rearrangements at the MLL breakpoint cluster, Nature Communications (2026). DOI: 10.1038/s41467-026-72034-2”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 11: “Secondary leukemias can develop when cellular stress caused by chemotherapy or radiotherapy triggers DNA breaks in specific regions of the genome.”
VERIFIED
General medical knowledge from NCI and Wikipedia confirms chemotherapy kills cancer cells and causes side effects. Specific research evidence provided in the web results for subsequent claims explicitly links chemotherapy-induced Endonuclease G activity to chromosomal breakage and leukemogenic rearrangements.
travel_explore
web search NEUTRAL — Chemotherapy (often abbreviated chemo, sometimes CTX and CTx) is the type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents or alkylating agents) in a standard regim…
https://en.wikipedia.org/wiki/Chemotherapy
travel_explore
web search NEUTRAL — Jun 26, 2026 · Chemotherapy is a common cancer treatment. Learn more about how it works, what to expect during treatment, common side effects, and other FAQs.
https://www.webmd.com/cancer/chemotherapy-what-to-expect
travel_explore
web search NEUTRAL — Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. Learn how chemotherapy works against cancer, why it causes side effects, and how it is used with other cancer treatment…
https://www.cancer.gov/about-cancer/treatment/types/chemothe…
verified
Claim 12: “This enzyme [endonuclease G (EndoG)] can cut DNA like a pair of molecular scissors.”
VERIFIED BY REFERENCE
GeneCards and PMC sources explicitly define Endonuclease G (EndoG) as an enzyme that cleaves DNA.
travel_explore
web search NEUTRAL — Jun 13, 2006 ... Our earlier studies had suggested that endonuclease G (EndoG), a member of the evolutionarily conserved DNA/RNA nonspecific ββα-Me-finger ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC1482554/
travel_explore
web search NEUTRAL — ENDOG encodes endonuclease G, a mitochondrial endonuclease that cleaves DNA at GC tracts and generates the RNA primers required by DNA polymerase gamma to ...
https://www.genecards.org/card/ENDOG
travel_explore
web search NEUTRAL — May 3, 2017 ... One member, EndoG, is the paralog of hEXOG. The nonspecific activity of EndoG is perfectly suited for activities during apoptosis when it ...
https://www.nature.com/articles/ncomms14959
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.